Pharma Journalist -

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on central nervous system (CNS) disorders, and Swedish R&D firm Dizlin Pharmaceuticals AB have…
Read More...

KalVista Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY (sebetralstat), a novel plasma kallikrein inhibitor, as the first and only…
Read More...

GSK plc has finalized its acquisition of efimosfermin alfa from Boston Pharmaceuticals, a promising investigational therapy targeting steatotic liver disease (SLD). Efimosfermin is a…
Read More...

Sagent Pharmaceuticals, a leading U.S. pharmaceutical provider, and China-based Qilu Pharmaceutical have entered a strategic partnership to commercialize a portfolio of complex…
Read More...

Chugai Pharmaceutical Co., Ltd., a major Japanese pharmaceutical company, and Singapore-based biotech firm Gero PTE. LTD. have announced a strategic joint research and license agreement…
Read More...

Mustang Bio, Inc., a clinical-stage biopharmaceutical company focused on cell therapies for hard-to-treat cancers, announced that the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Swiss biopharmaceutical company BioVersys AG has entered into a global research and exclusive license option agreement with Japanese pharmaceutical firm Shionogi & Co., Ltd. to…
Read More...

Brii Biosciences Limited, a biotechnology company focused on addressing high unmet medical needs, has announced a licensing and technology transfer agreement with Joincare…
Read More...

Jazz Pharmaceuticals plc announced that the European Commission (EC) has granted conditional marketing authorization for Ziihera® (zanidatamab), a dual HER2-targeted bispecific…
Read More...

Merck, known as MSD outside the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License…
Read More...